BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-160@pharmaconomics
DTSTAMP:20260707T034502Z
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260221
SUMMARY:VNDA Approval — Bysanti
DESCRIPTION:A final FDA approval decision on Bysanti for bipolar I disorder and schizophrenia is expected Feb 20\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1347178/000162828026031241/vnda8-k562026exhibit991.htm\n\nTrack it: https://www.pharmaconomics.com/e/160
URL:https://www.pharmaconomics.com/e/160
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VNDA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR